These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18450387)

  • 1. ING1a and ING1b different expressed in sporadic hepatocellular carcinoma.
    Chen X; Du J; Zhu T
    Pathol Biol (Paris); 2009 May; 57(3):e17-21. PubMed ID: 18450387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING1a expression increases during replicative senescence and induces a senescent phenotype.
    Soliman MA; Berardi P; Pastyryeva S; Bonnefin P; Feng X; Colina A; Young D; Riabowol K
    Aging Cell; 2008 Dec; 7(6):783-94. PubMed ID: 18691180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
    Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
    Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner.
    Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K
    Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
    Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
    Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor p33ING1b upregulates p16INK4a expression and induces cellular senescence.
    Li N; Li Q; Cao X; Zhao G; Xue L; Tong T
    FEBS Lett; 2011 Oct; 585(19):3106-12. PubMed ID: 21896275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
    Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
    Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.
    Chen LS; Wei JB; Zhou YC; Zhang S; Liang JL; Cao YF; Tang ZJ; Zhang XL; Gao F
    World J Gastroenterol; 2005 Oct; 11(39):6120-4. PubMed ID: 16273637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
    Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues.
    Walzak AA; Veldhoen N; Feng X; Riabowol K; Helbing CC
    Exp Cell Res; 2008 Jan; 314(2):273-85. PubMed ID: 17720155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of TANGO in colon and hepatocellular carcinomas.
    Arndt S; Bosserhoff AK
    Oncol Rep; 2007 Oct; 18(4):885-91. PubMed ID: 17786351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
    Hou YK; Wang Y; Cong WM; Wu MC
    Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.
    Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC
    Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F; Luo LB; Tao YM; Wu F; Yang LY
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.